CBIT Therapist Training for Tourette Syndrome
(CBIT-Trainer Trial)
Trial Summary
What is the purpose of this trial?
Tic disorders are a class of childhood-onset neuropsychiatric disorders that occur in 1-3% of the population. Studies have shown that a non-drug treatment known as Comprehensive Behavioral Intervention for Tics (CBIT) is more effective than supportive therapy for reducing tics in children and adults. Although CBIT is now recommended as a first-line intervention for tic disorders, many patients do not have access to CBIT, in part due to a lack of trained therapists. Currently, the only option available for training therapists in CBIT is an intensive, two day, in-person behavior therapy training institute (BTTI). This study will compare the traditional in-person training approach to a recently developed online, self-paced CBIT therapist training program called CBIT-Trainer with regard to (1) therapists' ability to accurately administer CBIT and (2) change in the severity of patients' tic symptoms after being treated by a CBIT-trained therapist.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on a behavioral therapy for tics, so it's best to discuss your medications with the study team or your doctor.
What data supports the effectiveness of this treatment for Tourette Syndrome?
Research shows that Comprehensive Behavioral Intervention for Tics (CBIT) is effective in reducing tic symptoms in people with Tourette Syndrome. Studies have demonstrated that CBIT can significantly decrease tic severity and improve daily functioning, making it a recommended first-line treatment for tic disorders.12345
Is CBIT safe for treating Tourette Syndrome?
How is the CBIT treatment different from other treatments for Tourette Syndrome?
CBIT (Comprehensive Behavioral Intervention for Tics) is unique because it is a non-drug therapy that focuses on behavioral techniques to manage tics, unlike most treatments that rely on medication. It has been shown to be effective in reducing tic severity and maintaining benefits over time, making it a first-line treatment option for Tourette Syndrome.12567
Research Team
Suzanne Mouton-Odum, PhD
Principal Investigator
PsycTech, LLC
Doug Woods, PhD
Principal Investigator
Marquette University
Michael Himle, PhD
Principal Investigator
University of Utah
Eligibility Criteria
This trial is for licensed therapists with a Master's degree or higher in mental/behavioral health, medical, or related fields. They must be able to travel for training and find at least one patient with tic disorders to participate. Patients should have a diagnosed tic disorder, be 7 years old or older, speak English fluently, and have internet access.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Training
Therapists undergo either in-person or online training to deliver CBIT
Treatment
Therapists administer CBIT to patients, and outcomes are assessed
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Behavior Therapy Training Institute
- CBIT-Trainer
Behavior Therapy Training Institute is already approved in United States, European Union for the following indications:
- Tic disorders
- Tourette syndrome
- Tic disorders
- Tourette syndrome
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor
PsycTech, LLC
Collaborator
Marquette University
Collaborator